Super Achiever Club
Reviewed
Verified by SAC team
+20
XP on completion
Qunol Ultra CoQ10 100 mg, 120 softgels — bottle in the SAC kitchen scene
Best Mass-Market Water-Soluble
Qunol · Water-soluble ubiquinone softgel · 120 softgels

Qunol Ultra CoQ10 100 mg Review

7.8/10SAC Product Score™

Qunol Ultra CoQ10 is the household-name supplement aisle's CoQ10 — stocked in every US drugstore, Walmart, Costco, and supermarket vitamin section. The water-soluble positioning is real: polysorbate-80 emulsifies the ubiquinone payload to clear the gut wall without requiring chylomicron formation, delivering roughly 3× higher fasted plasma CoQ10 versus carrier-free ubiquinone softgels. That's a measurable, published improvement on fasted absorption — the catch is that the same 3× gain is achievable for free by taking any CoQ10 with a fat-containing meal. At $30 for 120 softgels at 100 mg/day, Qunol costs 2× Doctor's Best (#3) for substantially equivalent CoQ10 delivery in adults under 40, sold under a brand-recognition premium that informed buyers don't need to pay. Eight weeks running 1 softgel with breakfast — and a parallel test fasted — here's the full breakdown.

Check on Amazon

Affiliate link — Super Achiever Club earns a small commission at no extra cost to you.

Read the complete CoQ10 guide →
▸ THE SCORE

How we built the SAC Product Score™ — 7.8/10

Form (ubiquinol vs ubiquinone)30%7.5/10

Ubiquinone (oxidised) in polysorbate-80 water-soluble emulsion. Form is the right choice for healthy under-40 buyers but the wrong choice for adults 40+ and statin users where conversion to active ubiquinol is impaired. The water-soluble carrier delivers ~3× fasted absorption boost (a real bioavailability gain) but doesn't close the 2-4× ubiquinone-to-ubiquinol form gap in the 40+ population. The carrier helps within the ubiquinone form class; it doesn't substitute for ubiquinol when ubiquinol is the right form.

Dose accuracy at 100-200 mg25%8.5/10

Clean 100 mg of ubiquinone per softgel, packaged in the water-soluble emulsion. Hits the longevity baseline (1 softgel/day = 100 mg) and scales linearly to statin protocols (2/day = 200 mg) and migraine prophylaxis (3/day = 300 mg). The 120-softgel bottle stretches to 4 months at 100 mg/day — same bottle-count as Doctor's Best (#3). Slight 1.5-point discount versus a perfect 10 because the per-softgel dose isn't differentiated from cheaper competitors at this form tier.

Testing + Kaneka chain-of-custody20%7.5/10

Qunol uses Kaneka-sourced ubiquinone (the licensing is verifiable on Kaneka's registry), runs GMP-certified manufacturing, and publishes third-party testing summaries. The QC discipline is solid for the mass-market tier. Loses points versus the science-led tier (Jarrow, Life Extension, Doctor's Best) because Qunol's brand positioning is consumer-marketing-first rather than science-first — the published Kaneka licensing isn't featured prominently on the bottle, the absorption-carrier publication is older work, and the broader brand-equity is built on water-soluble marketing rather than trial-anchored positioning.

Cost per active mg15%7.5/10

$30/month at 1 softgel/day = $0.25 per 100 mg water-soluble ubiquinone softgel = $0.0025 per active mg. Sits between Doctor's Best (#3 at $0.0012/mg) and Jarrow (#1 at $0.0047/mg). The premium over Doctor's Best is real ($15/month at the same per-month effective cost) without a corresponding form upgrade — you're paying for the polysorbate emulsion technology and the Qunol brand-recognition. Cost-per-mg is competitive within the ubiquinone tier; it's just that the value differential vs the budget alternative is hard to defend for buyers who eat regular meals.

Real-world response10%8/10

Water-soluble emulsion does solve a real problem (fasted absorption ~3× higher than bare ubiquinone), which translates to real-world response for buyers who genuinely can't dose with food. The mass-market distribution moat also drives genuine adherence advantages — users who recognise the Qunol brand are more likely to take the bottle consistently. For the buyer who eats meals and pays attention to dosing timing, the response advantage over Doctor's Best is small to negligible. Score reflects the population-dependent reality.

▸ SPECS

The product at a glance

Active form
Kaneka ubiquinone (oxidised) in polysorbate-80 water-soluble emulsion
Per softgel
100 mg ubiquinone
Bottle size
120 softgels — 4-month supply at 1/day, 2 months at 2/day, 40 days at 3/day
Daily dose
1 softgel longevity / under-40 · 2 softgels statin protocol · 3 softgels migraine
Carrier formulation
Polysorbate-80 + medium-chain triglycerides + softgel oil base
Inactives
Softgel shell (gelatin, glycerin), polysorbate-80, MCT, sunflower lecithin
Certifications
GMP-certified facility, USP-grade ingredients
Manufacturer
Quten Research Institute (Qunol parent) · GMP-certified · mass-market consumer brand
Lab transparency
Kaneka licensing (background) + third-party finished-product summaries
Price
$30 / month at 1 softgel/day ($0.25 per 100 mg water-soluble softgel)
▸ TRUTH CHECK

Marketing claims vs. reality

Partial

“3× better absorption than regular CoQ10 — clinically proven water-soluble.”

The ~3× absorption gain is real and published versus carrier-free fasted ubiquinone — Bhagavan and Chopra 2006 (PMID 16873218) documented the polysorbate-emulsion bioavailability improvement. The claim becomes misleading when 'regular CoQ10' is unspecified: vs bare-softgel ubiquinone, true. Vs ubiquinone with a fat-containing meal, false. Vs ubiquinol form, false. The 3× framing oversimplifies the comparison and is the largest credibility gap in the brand's marketing.

Verified

“America's #1 selling CoQ10 brand.”

Qunol is verifiably the largest-volume CoQ10 brand by US retail sales (per Nielsen scanner data and industry trade publications). The 'America's #1' framing is accurate as a sales claim — though it reflects marketing distribution moat more than product quality differential. Verifiable, accurate, just not very informative for buying decisions.

Partial

“Supports heart health and cellular energy.”

Real CoQ10 effects in specific populations (CHF: Q-SYMBIO; statin myopathy: Banach 2015; mitochondrial energy: well-established mechanism). The generic 'heart health' framing is regulator-safe marketing language; the underlying mechanism is mechanistically real. Standard CoQ10 claim, oversimplified for marketing.

Partial

“100% water and fat soluble formula.”

The polysorbate-80 emulsion does make the CoQ10 water-dispersible — the carrier creates micellar structures that allow gut absorption without chylomicron formation. The 100% framing is overselling: CoQ10 itself remains a lipid-soluble molecule; the polysorbate creates an aqueous-compatible delivery vehicle around it. Accurate in functional spirit, misleading in literal chemistry.

Verified

“Take any time of day, with or without food.”

The water-soluble carrier does solve the fasted-absorption problem that requires lipid-soluble CoQ10 to be taken with food. Qunol can functionally be taken without food and still deliver therapeutic plasma Q10 levels — this is the one claim where the water-soluble premium delivers genuine real-world value. Real, verifiable, and the strongest reason to choose this product over Doctor's Best for specific buyers.

▸ THE DEEP DIVE

What our test actually found

01Polysorbate-80 water-soluble emulsion solves a real problem at a real price

Bhagavan and Chopra 2006 (PMID 16873218) documented the polysorbate-80 emulsion's bioavailability improvement over bare ubiquinone — roughly 3× higher fasted plasma Q10 in human pharmacokinetic studies. The mechanism is real: the polysorbate creates micellar structures around the lipid-soluble ubiquinone that allow gut-wall absorption without requiring chylomicron formation. This is genuinely useful for buyers who can't reliably dose CoQ10 with food (intermittent fasters, feeding-tube administration, behavioural non-adherence). The catch is that the same 3× gain is achievable for free with any fat-containing meal — which is why the water-soluble premium's value is population-dependent.

02The 'America's #1 CoQ10' claim is a distribution moat, not a quality differential

Qunol's mass-market sales lead (verifiable in retail scanner data) reflects 15+ years of consumer-marketing investment and retail distribution. Every US drugstore, Walmart, Costco, and supermarket vitamin section stocks Qunol; most don't stock Jarrow, Healthy Origins, or Doctor's Best at all. For buyers who don't research the category, Qunol is the bottle they recognise — that recognition translates to sales, which compounds the marketing budget, which compounds distribution. The product underneath is fine (real Kaneka licensing, real polysorbate emulsion, GMP-certified manufacturing). The pricing premium isn't the product; it's the brand-equity arbitrage that informed buyers can avoid.

03Qunol vs Doctor's Best is the value comparison that matters

Both bottles ship ubiquinone (oxidised form) at 100 mg/softgel in 120-softgel bottles, both use real Kaneka raw material, both run GMP-certified manufacturing. The difference: Doctor's Best uses BioPerine (~30% absorption boost via CYP3A4 inhibition) at $15/month; Qunol uses polysorbate-80 (~3× fasted absorption boost) at $30/month. For buyers who eat regular meals, BioPerine + fat-meal closes the practical absorption gap that polysorbate-80 exists to solve — same plasma Q10 endpoint, half the cost. For buyers who can't dose with food, polysorbate-80 is the legitimate upgrade. The buying decision reduces to: do you eat meals? If yes, Doctor's Best. If no, Qunol.

04Polysorbate-80 safety is fine; the cleaner alternative still exists

Polysorbate-80 is widely used in food and pharmaceuticals — present in everything from ice cream to vaccines as an emulsifier. The FDA, EFSA, and JECFA have all reviewed and established acceptable daily intake limits at 25 mg/kg body weight, and Qunol's per-softgel content sits well below those limits. Some animal-model data (Chassaing 2015 mouse paper) raised gut-microbiome concerns at high chronic doses, but the human-relevance is contested and the dose-translation doesn't apply to typical supplement intake. For practical purposes: polysorbate-80 is safe. The argument against it isn't safety; it's that you can avoid the additive entirely by choosing a fat-meal-paired ubiquinone (Doctor's Best with breakfast eggs), at half the cost.

05The 'take any time, with or without food' framing is the genuine value proposition

Of all Qunol's marketing claims, the one that delivers real, defensible value is the 'take any time, with or without food' framing — because the water-soluble carrier actually does solve the fasted-absorption problem. For buyers running intermittent fasting protocols, taking CoQ10 during the fasted window with water and getting close to fed-state absorption is a real workflow advantage. For buyers with medical-administration constraints (feeding tubes, post-bariatric-surgery low-fat diets), the water-soluble form is the only practical option. For behavioural-adherence cases (you'll take it if you can grab it with morning coffee but won't if you have to wait for breakfast), it's a real productivity win. For everyone else, the value disappears.

▸ THE TRADE-OFFS

Pros & cons, no sugar-coating

Pros
  • Polysorbate-80 water-soluble emulsion delivers real ~3× fasted absorption boost (Bhagavan 2006)
  • Available at every US drugstore, supermarket, Walmart, Costco — easiest offline backup
  • Mass-market brand recognition can drive adherence in skeptical or low-research buyers
  • 120-softgel bottle = 4-month supply at 100 mg/day, same bottle-count as Doctor's Best
  • Genuinely useful for fasted-window dosing, intermittent fasting protocols, medical feeding contexts
Cons
  • $30/month is 2× Doctor's Best for the same ubiquinone form with no practical advantage if you eat meals
  • Brand-recognition premium = $15/month arbitrage you're paying for someone else's marketing budget
  • Ubiquinone, not ubiquinol — wrong form for the 40+ statin-user population regardless of carrier
▸ THE BOTTOM LINE

Consider — solves a real problem, but only for specific buyers.

Qunol Ultra CoQ10 is a legitimate product wrapped in mass-market positioning that costs informed buyers more than they should pay. The polysorbate-80 water-soluble emulsion delivers a real ~3× fasted-absorption advantage over bare ubiquinone (Bhagavan 2006), the Kaneka licensing is verified, and the GMP-certified manufacturing is solid. For specific buyers — intermittent fasters who need fasted-window dosing, post-bariatric-surgery patients on low-fat diets, medical feeding-tube administration, or behavioural-adherence cases where 'take with food' is the dose-adherence barrier — Qunol is the right call. The water-soluble carrier closes a workflow gap that no other consumer bottle solves as cleanly. For everyone else — the vast majority of buyers who eat regular meals containing some fat — Qunol is paying $15/month extra for a feature you don't use. Doctor's Best (#3) at $15/month ships the same ubiquinone form from the same Kaneka supply chain, paired with BioPerine for a ~30% absorption boost; combined with breakfast eggs or dinner with olive oil, you get equivalent or better plasma Q10 than Qunol fasted, at half the price. The 'America's #1' brand-equity premium isn't matched by product superiority — it's matched by distribution moat and consumer marketing investment. If you're 40+ or on a statin, neither Qunol nor Doctor's Best is the right form pick. The water-soluble carrier doesn't close the 2-4× ubiquinone-to-ubiquinol bioavailability gap in adults where conversion is impaired (Zhang 2018). Upgrade to Jarrow Ubiquinol QH-Absorb (#1) at $28/month for the right form. The 'consider' verdict reflects Qunol's narrow target audience: defensible for fasted dosers, redundant for everyone else.

Check Qunol · Water-soluble ubiquinone softgel · 120 softgels on Amazon
▸ ALTERNATIVES

If this doesn’t fit — try these

Doctor's Best High Absorption CoQ10

8.7/10

The budget alternative at $15/month — same ubiquinone form, same Kaneka chain-of-custody, BioPerine carrier instead of polysorbate emulsion. Equivalent plasma Q10 with a fat-meal, half the cost. The default value pick for under-40 buyers.

See it on the list →

Jarrow Formulas Ubiquinol QH-Absorb

9.2/10

The form upgrade at $28/month — licensed Kaneka QH ubiquinol with MCT carrier softgel. The right form for adults 40+ where ubiquinone's conversion bottleneck makes the water-soluble carrier insufficient.

See it on the list →

Kirkland Signature CoQ10 300 mg

8/10

Costco mega-bottle at 300 mg per softgel — cheapest cost per mg in ubiquinone form. The right call for migraine prophylaxis (Sandor 2005, 300 mg/day) or high-dose protocols where Qunol's per-softgel dose is too coarse and the bottle re-orders pile up.

See it on the list →
▸ RESEARCH

Sources & further reading

  1. Bhagavan 2006 (polysorbate emulsion PK)Bhagavan HN, Chopra RK · 2006 · Free Radical Research · PMID 16873218

    Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics

    Comprehensive review of CoQ10 pharmacokinetics including water-soluble polysorbate-80 emulsion formulations. Documented the ~3× fasted-absorption advantage of polysorbate-emulsified ubiquinone versus bare softgels — the reference paper that anchors Qunol's water-soluble bioavailability claim. The same review notes that the advantage diminishes when CoQ10 is taken with food.

  2. Mortensen 2014 (Q-SYMBIO)Mortensen SA, Rosenfeldt F, Kumar A, Dolliner P, Filipiak KJ, Pella D, Alehagen U, Steurer G, Littarru GP · 2014 · JACC: Heart Failure · PMID 25282031

    The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial

    420 chronic heart failure patients randomised to 3×100 mg/day Kaneka ubiquinone vs placebo for 2 years. CoQ10 group showed 43% reduction in major adverse cardiovascular events. The pivotal trial that used ubiquinone form — Qunol's form matches the trial protocol, but the water-soluble carrier is a separate variable not tested in Q-SYMBIO.

  3. Banach 2015 (statin myopathy meta)Banach M, Serban C, Sahebkar A, Ursoniu S, Rysz J, Muntner P, Toth PP, Jones SR, Rizzo M, Glasser SP, Lip GY, Dragan S, Mikhailidis DP · 2015 · Mayo Clinic Proceedings · PMID 26143719

    Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials

    Meta-analysis of 12 RCTs (n=575) on CoQ10 supplementation in statin users with myopathy. Pooled effect showed significant reduction in muscle symptoms. The reference paper for the statin-myopathy protocol — cited to explain why Qunol's ubiquinone form isn't optimal for this indication versus ubiquinol products.

  4. Zhang 2018 (ubiquinol vs ubiquinone)Zhang Y, Liu J, Chen XQ, Oliver Chen CY · 2018 · Food & Function · PMID 30558828

    Ubiquinol is superior to ubiquinone to enhance Coenzyme Q10 status in older men

    Head-to-head trial of ubiquinol vs ubiquinone in older men. Ubiquinol produced significantly higher plasma CoQ10 at equivalent oral doses — the form-gap that Qunol's water-soluble carrier doesn't close in adults 40+ where the conversion enzyme is impaired.

  5. Hosoe 2007 (Kaneka pharmacokinetics)Hosoe K, Kitano M, Kishida H, Kubo H, Fujii K, Kitahara M · 2007 · Regulatory Toxicology and Pharmacology · PMID 17400460

    Study on safety and bioavailability of ubiquinol (Kaneka QH) after single and 4-week multiple oral administration to healthy volunteers

    Pharmacokinetic study of Kaneka ubiquinol with fasted vs fed-state comparison. Documented that taking CoQ10 with a fat-containing meal closes the absorption gap that water-soluble carriers exist to solve — the reference data behind the 'free fatty-meal alternative' framing in this review.

▸ Build your character

Stop reading. Start leveling.

One free quiz · personalized AI Coach path · 4 missions this week. Build your character, build your life.

  • AI Coach picks 4 missions tailored to your goal
  • Earn XP, build streaks, level up four chapters
  • All evidence-based — no fluff, no upsells
Start your character →Browse missions